Emma Childs1, Harriet de Wit. 1. Department of Psychiatry and Behavioural Neuroscience, The University of Chicago, 5841 S. Maryland Ave., MC 3077, Chicago, IL, 60637, USA. echilds@uchicago.edu
Abstract
RATIONALE: There are complex relationships between stress and smoking; smoking may reduce the emotional discomfort of stress, yet nicotine activates stress systems and may alter responses to acute stress. It is important to understand how smoking affects physiological and psychological outcomes after stress and how these may interact to motivate smoking. OBJECTIVES: This study aimed to examine the magnitude and time course of hormonal, cardiovascular, and psychological responses to acute psychosocial stress in smokers and non-smokers to investigate whether responses to acute stress are altered in smokers. MATERIALS AND METHODS: Healthy male non-smokers (n = 20) and smokers (n = 15) participated in two experimental sessions involving a standardized public speaking stress procedure and a control non-stressful task. The outcome measures included self-reported mood, cardiovascular measures (heart rate and blood pressure), and plasma hormone levels (noradrenaline, cortisol, progesterone, and allopregnanolone). RESULTS: Smokers exhibited blunted increases in cortisol after the Trier Social Stress Test, and they reported greater and more prolonged subjective agitation than non-smokers. Stress-induced changes in progesterone were similar between smokers and non-smokers, although responses overall were smaller among smokers. Stress did not significantly alter levels of allopregnanolone, but smokers exhibited lower plasma concentrations of this neurosteroid. CONCLUSIONS: These findings suggest that smoking dampens hormonal responses to stress and prolongs subjective discomfort. Dysregulated stress responses may represent a breakdown in the body's ability to cope efficiently and effectively with stress and may contribute to smokers' susceptibility to acute stress, especially during abstinence.
RATIONALE: There are complex relationships between stress and smoking; smoking may reduce the emotional discomfort of stress, yet nicotine activates stress systems and may alter responses to acute stress. It is important to understand how smoking affects physiological and psychological outcomes after stress and how these may interact to motivate smoking. OBJECTIVES: This study aimed to examine the magnitude and time course of hormonal, cardiovascular, and psychological responses to acute psychosocial stress in smokers and non-smokers to investigate whether responses to acute stress are altered in smokers. MATERIALS AND METHODS: Healthy male non-smokers (n = 20) and smokers (n = 15) participated in two experimental sessions involving a standardized public speaking stress procedure and a control non-stressful task. The outcome measures included self-reported mood, cardiovascular measures (heart rate and blood pressure), and plasma hormone levels (noradrenaline, cortisol, progesterone, and allopregnanolone). RESULTS: Smokers exhibited blunted increases in cortisol after the Trier Social Stress Test, and they reported greater and more prolonged subjective agitation than non-smokers. Stress-induced changes in progesterone were similar between smokers and non-smokers, although responses overall were smaller among smokers. Stress did not significantly alter levels of allopregnanolone, but smokers exhibited lower plasma concentrations of this neurosteroid. CONCLUSIONS: These findings suggest that smoking dampens hormonal responses to stress and prolongs subjective discomfort. Dysregulated stress responses may represent a breakdown in the body's ability to cope efficiently and effectively with stress and may contribute to smokers' susceptibility to acute stress, especially during abstinence.
Authors: Sudie E Back; Angela E Waldrop; Michael E Saladin; Sharon D Yeatts; Annie Simpson; Aimee L McRae; Himanshu P Upadhyaya; Regana Contini Sisson; Eve G Spratt; Julia Allen; Mary Jeanne Kreek; Kathleen T Brady Journal: Psychoneuroendocrinology Date: 2008-03-05 Impact factor: 4.905
Authors: Jeanette M Bennett; Ronald Glaser; Rebecca R Andridge; Juan Peng; William B Malarkey; Janice K Kiecolt-Glaser Journal: Psychoneuroendocrinology Date: 2012-06-21 Impact factor: 4.905
Authors: Jessica M Richards; Brooke A Stipelman; Marina A Bornovalova; Stacey B Daughters; Rajita Sinha; C W Lejuez Journal: Biol Psychol Date: 2011-07-07 Impact factor: 3.251
Authors: Sherry A McKee; Rajita Sinha; Andrea H Weinberger; Mehmet Sofuoglu; Emily L R Harrison; Meaghan Lavery; Jesse Wanzer Journal: J Psychopharmacol Date: 2010-09-03 Impact factor: 4.153